Trends in pediatric nonprescription analgesic/antipyretic exposures during the COVID-19 pandemic.

ABSTRACT:

Objective

To examine pediatric exposure trends involving selected nonprescription analgesics/antipyretics, before and during the COVID-19 pandemic.

Methods

Using descriptive and interrupted time-series analyses, we assessed monthly United States poison center data involving pediatric (<18 years) exposures to nonprescription paracetamol (acetaminophen), ibuprofen, acetylsalicylic acid, and naproxen before (January 2015-February 2020) and during (March 2020-April 2021) the pandemic. Statins and proton pump inhibitors (prescription or nonprescription) served as controls.

Results

Most nonprescription analgesic/antipyretic exposures (75-90%) were single-substance; unintentional exposures typically involved children <6 years (84-92%), while intentional exposures involved fe

SUBMITTER: Karami S 

PROVIDER: S-EPMC12548374 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature